← signals
2026-06-30·ASML·export restriction
lowup

Multiple prediction markets on Manifold (as of June 30, 2026) collectively indicate a low likelihood of US-imposed...

Multiple prediction markets on Manifold (as of June 30, 2026) collectively indicate a low likelihood of US-imposed export restrictions on ASML to China and reaffirm ASML's dominant EUV monopoly.

window 30devidence 10price ASML $1794.62
priced-in check

ASML has already moved up +38% over the recent 30-90 day window.

partly priced
as of 2026-06-267d n/a45d n/a90d +38%yahoo

signal brief

Multiple prediction markets on Manifold (as of June 30, 2026) collectively indicate a low likelihood of US-imposed export restrictions on ASML to China and reaffirm ASML's dominant EUV monopoly. Source 1 shows only a 28.6% probability that the US will force ASML to halt exports to China before 2029, suggesting market participants do not expect a near-term regulatory crackdown. Source 8 gives a 96.17% probability that ASML remains a monopoly in EUV lithography through end of 2024, and sources 3 and 5 extend that dominance through 2026 (79.92%) and 2027 (69.43%). Meanwhile, source 7 indicates a 56.45% chance China develops a domestic EUV by 2030, which is a long-term competitive threat but not imminent. Source 9 shows only a 6.28% probability ASML sold EUV machines to China in 2023, reinforcing compliance. Source 4 forecasts revenue growth with 83.77% probability. These prediction market probabilities, while not hard evidence, suggest the market sees ASML's regulatory risk as low and its competitive moat as durable. For the AI-infra and semiconductor ecosystem, this implies continued reliance on ASML for advanced node production, benefiting downstream hyperscalers and chipmakers. However, the probability of a future export halt is non-zero, and the Chinese domestic EUV effort is a known risk. Given the source type (prediction market), confidence is low.

evidence

spillover entities

Decision support, not stock advice. This signal is research with cited evidence — not a recommendation to buy, sell, or hold any security.